The Board of directors manages the Foundation and ensure that its assets are devoted to the meet the objectives of the Foundation.
The Board adopts the regulations necessary for its own running and the running of the Foundation in general.
The Board establishes the budget for each accounting period and publishes an annual written report on its management. It approves the annual Balance Sheet and Profit and Loss Account.
MD, President of the Board, Coordinator of Laboratory medicine
Michelle Rossier received an M.D. from the University of Lausanne (Switzerland) and completed a MD thesis medical Department of Physiology of the University of Geneva. After a postdoctoral research fellowship, she held an assistant research physiologist position at the Department of Physiology, University of California, San Francisco. She then returned to the Institute of Pharmacology at the University of Lausanne, where she became a « maître assistant ». From 1977 to 2006 she was Director of the clinical laboratories of Hematology, Clinical Chemistry and Microbiology at the Hospital of Morges, Switzerland. In 2001 she held the same position with Viollier Inc., one of the largest private clinical laboratories in Switzerland. She joined the HSeT core team in February 2006 to become a project coordinator for several HSeT projects.
MD PhD, CEO and coordinator of Microbiology and Oncology
Jean-Pierre Kraehenbuhl is the Chief Executive Officer of HSeT. He is emeritus Professor at the University of Lausanne, and was affiliated member of the Swiss Institute of Cancer Research (ISREC). He used to work on mucosal immunity and vaccinology. He was a co-founder of EuroVacc, a Foundation active in the development of HIV vaccines, He is a member of EMBO. He was the co- founder of OraVax, Inc, now part of Sanofi Pasteur. He is co-leader of OCTAVE, the Online Collaborative Training of AIDS Vaccine Evaluation.
Phone: +41 21 692 5856
Address: HSeT Foundation
c/o Center of Immunity and Infection (CIIL)
Chemin des Boveresses 155
CH-1066 Epalinges, Switzerland
PhD. Innovation lab : vaccines Institut Pasteur, Paris France
Armelle Phalipon has lead the group working on adaptive immunity to Shigella infection and development of vaccine strategies in the Molecular Microbial Pathogenesis Unit directed by Professor Philippe Sansonetti (Institut Pasteur). With more than 15 years of experience working on Shigella, she has deciphered the targets and effectors of the humoral response to infection and discovered two novel molecular mechanisms of secretory IgA-mediated protection at mucosal surfaces. She is currently studying the direct targeting of cells of the adaptive immunity by Shigella virulence effectors and its consequence in term of induction of the adaptive immune response. Dr. Phalipon has a long-standing interest in combining fundamental and applied research, as exemplified by her participation in the development of dipsticks for diagnosis of shigellosis in emergency conditions based on the use of monoclonal antibodies, generated by her, for fundamental research purposes. In addition, in collaboration with Dr. Laurence Mulard (Chemistry of Biomolecules Unit, Institut Pasteur), she has developed an alternative approach to design subunit vaccines to Shigella infection, i.e. chemically defined glycoconjugate vaccines based on the use of synthetic oligosaccharides mimicking the protective epitopes of the polysaccharide moiety of lipopolysaccharide, the main protective Shigella antigen. A phase I trial will be started in 2016. Dr. Phalipon has been member of the WHO Steering Committee for Diarrheoal Diseases. Deeply involved since many years in teaching activities both at the national and international level, she launched in collaboration with Frédéric Tangy the first Vaccinology Course at the Pasteur Institute in 2008.
Address: Institut Pasteur
28 Rue du Dr. Roux
75724 Paris Cedex 15, France
MD, Associate Professor , Internal Medicine & Nephrology, Medical Faculty Bern University
Uyen Huynh-Do is Associate Professor of Internal Medicine and Nephrology at the Faculty of Medicine of the University of Bern. She was trained as an MD at the University of Zurich, then specialized in renal physiology and hypertension. From 1996 to 1999 Uyen Huynh-Do joined the Division of Nephrology and the Vanderbilt Center for Vascular Biology at Vanderbilt University Medical Center (Nashville, TN) as a Postdoctoral Research Fellow. In 2004 she was appointed Assistant Professor, and in 2008 Associate Professor at the University Hospital of Bern. In 2009 she received a Master of Medical Education (MME) from the University of Bern and the Department of Medical Education, University of Illinois at Chicago. She is the director of the interuniversitary PhD and Postdoctoral programme IKPP (Integrative Kidney Physiology and Pathophysiology) supported by both the Swiss National Science Foundation and the European Union (Marie Curie FP7 Co-Fund).
MD, MHPE, Vice Dean Medical education, Medical Faculty Geneva University
Mathieu Nendaz is an internist at the Geneva University Hospitals and trained in health professions education at the University of Illinois at Chicago. He is presently also Director of the Unit of Development and Research (UDREM) and Professor at the Faculty of Medicine, University of Geneva, Switzerland. His research interests include Internal Medicine and Medical Education. In this field, he is particularly interested in decision-making, clinical reasoning, clinical supervision, and interprofessional issues. He is deeply involved in direct teaching, clinical supervision and training, as well as in the development and organization of teaching concepts and medical curriculum.
MD, PhD, Professor, Swiss Federal Institute of Technology
Trained as an MD, William F. Pralong did his Thesis in Transport Phenomena at the Dpt of Pharmacology, School of Medicine in Geneva. He specialized then in Diabetes and Pancreas Physiology. He moved to industry to work on artificial pancreas and then conducted clinical trials in genetherapy for EPO delivery at the Dept of Experimental Surgery with Patrick Aebischer at the CHUV, Lausanne. He joined EPFL in 2000 with EPFL’s President, Patrick Aebischer to set up the curriculum in Life Sciences and Technology and in Bioengineering at the School of Life Sciences. Presently William Pralong is Deputy to the Provost for MQS at the Swiss Federal Institute of Technology.
PhD, Emeritus Professor, Pathology & Immunology, University of Geneva
The laboratory of Walter Reith has a long-standing interest in molecular and cellular immunology. Major themes of past research have included the genetic control and biological functions of Major Histocompatibility Complex class II (MHCII) mediated antigen presentation in humans and mice in the context of health and disease.
Current topics focus on the molecular and cellular mechanisms that regulate gene expression in specialized antigen presenting cells (APCs) – including B cells, various dendritic cell (DC) subsets and thymic epithelial cells – and the functions of these APCs in adaptive immune responses, the physiological processes that mediate the establishment and maintenance of immunological self-tolerance, and the pathological mechanisms that underpin the breakdown of immunological self-tolerance during the course of autoimmune diseases.
Phone: +41 79 250 3539
Address: Faculty of medicine
University of Geneva
1 rue Michel-Servet
Attorney at Kellerhals Carrard Law Firm, Lausanne, Switzterland
Dr Frédéric Rochat was admitted as an attorney-at-law to the bars of the Canton of Vaud (2002) and New York (2005). He is a partner at the law firm of Carrard & Associés in Lausanne, Switzerland, specializing in corporate and contract law. In parallel he teaches law at various institutions.
Prior to joining Carrard & Associés in 2007, Frédéric earned his law degree in 1996 from the universities of Lausanne and Berne. While working as a teaching and research assistant in the fields of contract and securities law he obtained his doctorate from the University of Lausanne in 2002. He completed his two-year attorney traineeship and worked as an associate for one additional year in a business law firm in Lausanne, before leaving for the U.S. to obtain an LL.M. degree from Columbia University. From 2004 to 2007 he worked in the M& A and securities departments of the law firm of Simpson Thacher & Bartlett LLP in New York (2004-2005) and London (2006-2007).
MD, coordinator of Nephrology, Pharmacology and Toxicology
Bernard Rossier, emeritus Professor and former Director of the Department of Pharmacology and Toxicology and former Dean of the Faculty of Biology and Medicine of the University of Lausanne, is presently leading a research group working in the field of hypertension. He is recipient of many international Prizes in the field of nephrology. He is a member of EMBO, the Academia Europaea, the deutsche Akademie der Naturforscher Leopoldina, and is a Foreign Honorary member of the American Academy of Arts and Sciences. He is Dr. honoris causa of the University Pierre et Marie Curie in Paris. He is member of the Louis Jeantet Foundation in Geneva and the Cloetta Foundation in Zurich.
Amadou Alpha Sall
PhD, Director of the Institut Pasteur of Dakar, Senegal
Amadou A Sall is a virologist and has a PhD in Public health. He received his scientific education at Universities Paul Sabatier at Toulouse, Paris Orsay and Pierre et Marie Curie in France. He has also visited several laboratories for his training including Institut Pasteur in Paris (France), Institute of Virology and environmental medicine in Oxford (United Kingdom), Center for tropical disease at the University of Texas Medical Branch at Galveston (USA) or Albert Einstein College of Medicine of Yeshiva University at New York. He is currently the head of the Arboviruses and viral hemorrhagic fever unit, director of the WHO collaborating center and scientific Director of Institut Pasteur de Dakar which belongs to the Institut Pasteur International Network. His research focused primarily on ecology and evolution of arboviruses and viral hemorrhagic fever and diagnostics of the latter viruses is a priority in his laboratory. Dr Sall has worked for 2 years in Cambodia on hepatitis B and C viruses. He was a Visiting Research Scientist at the Center for Infection and immunity at the Mailman School of Public health of Columbia University and worked for a year on pathogen discovery. He has published more than 90 papers and book chapters and give more than 150 scientific communications in international meetings.
Professor, University of Neuchâtel.
Professor of Health Law at the Law Faculty of the University of Neuchâtel (Switzerland). Founder and Deputy Director of the Institute of Health Law of the University of Neuchâtel, one of the 5 academic centers of the World Medical Association since 2013.
He was invited professor at the University of Montreal (Canada) in 2002 and at the National Tsing Hua University (Taiwan) in 2014. He is vice-director of the Swiss School of Public Health (SSPH+) and of the Ecole Romande de santé publique(ERSP) and also vice-president of the Board of the Réseau Fribourgeois de Santé Mentale, (RFSM) Expert in legisprudence, he collaborated in the drafting of several legislations in the field of health and healthcare at the Swiss and European level. He is also regularly invited by scientific and professional association in developing their guidelines in those fields. For instance, he coordinated the drafting of the Olympic Movement Medical Code for the IOC in 2006 and contributed to the 2008 and 2013 revision of the Declaration of Helsinki of the World Medical Association.
Expert in the field of patient’s rights and public health law with special interest in the regulation of research with human subjects, patient’s rights, the regulation of healthcare professionals, pharmaceutical and food stuff regulation, he has written more than 100 scientific publications, articles and book chapters on those issues. He is invited as expert by several organizations working in the field of health law and ethics at the national and international level (e.g. Swiss Academy of Medical Sciences, Council of Europe, European Union, World Medical Association, World Health Organization). He is one of the founder of the European Network of Research Ethics Committees supported by the European Commission. Since 2006, he is also the coordinator of the initiative Training and Resources in Research Ethics Evaluation (TRREE) which aims at providing a free, open access and multilingual online training program in research ethics and regulation.
MD, Emeritus Professor, University of Zürich
François Verrey is Professor Emeritus of Physiology at the University of Zurich. After high school in Zurich and medical school in Lausanne, he acted as ICRC delegate in Israel and resident in Internal Medicine at the CHUV. He then worked as postdoctoral fellow at the University of Lausanne, the ISREC and Columbia University, and started 1991 his own research group at the Institute of Physiology of the University of Zurich. He became Professor in 2001 and was director of the Institute from 2006-2014. He was vice-dean of the Faculty of Medicine, member of the research council of the SNSF and founder and director of the National Center of Competence in Research Kidney.CH until 2018. His research centered around epithelial transports in kidney and intestine, mainly regarding aldosterone-regulated sodium transport, and later transport and role of amino acids. Currently he is mainly engaged in the HSeT Foundation and as vice-director of the Swiss Kidney Foundation.
Phone: +41 44 635 50 44
Address: Institute of PhysiologyUniversity of Zürich, Winterthurerstrasse 190, 8032 Zurich